EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Combined Ferritin Nanocarriers with ICG for Effective Phototherapy Against Breast Cancer

Leopoldo Sitia iD, Paola Saccomandi iD, Leonardo Bianchi iD, Marta Sevieri iD, Cristina Sottani iD, Raffaele Allevi iD, Elena Grignani iD, Serena Mazzucchelli iD, Fabio Corsi iD

International Journal of Nanomedicine · 2024-05 · Volume 19 · 4263-4278

DOI: 10.2147/ijn.s445334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-05. Verfasst von Leopoldo Sitia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Università degli studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Indocyanine Green, Nanoparticles, Photochemotherapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Photodynamic Therapy (PDT) is a promising, minimally invasive treatment for cancer with high immunostimulatory potential, no reported drug resistance, and reduced side effects. Indocyanine Green (ICG) has been used as a photosensitizer (PS) for PDT, although its poor stability and low tumor-target specificity strongly limit its efficacy. To overcome these limitations, ICG can be formulated as a tumor-targeting nanoparticle (NP).

Methods

We nanoformulated ICG into recombinant heavy-ferritin nanocages (HFn-ICG). HFn has a specific interaction with transferrin receptor 1 (TfR1), which is overexpressed in most tumors, thus increasing HFn tumor tropism. First, we tested the properties of HFn-ICG as a PS upon irradiation with a continuous-wave diode laser. Then, we evaluated PDT efficacy in two breast cancer (BC) cell lines with different TfR1 expression levels. Finally, we measured the levels of intracellular endogenous heavy ferritin (H-Fn) after PDT treatment. In fact, it is known that cells undergoing ROS-induced autophagy, as in PDT, tend to increase their ferritin levels as a defence mechanism. By measuring intracellular H-Fn, we verified whether this interplay between internalized HFn and endogenous H-Fn could be used to maximize HFn uptake and PDT efficacy.

Results

We previously demonstrated that HFn-ICG stabilized ICG molecules and increased their delivery to the target site in vitro and in vivo for fluorescence guided surgery. Here, with the aim of using HFn-ICG for PDT, we showed that HFn-ICG improved treatment efficacy in BC cells, depending on their TfR1 expression. Our data revealed that endogenous H-Fn levels were increased after PDT treatment, suggesting that this defence reaction against oxidative stress could be used to enhance HFn-ICG uptake in cells, increasing treatment efficacy.

Conclusion

The strong PDT efficacy and peculiar Trojan horse-like mechanism, that we revealed for the first time in literature, confirmed the promising application of HFn-ICG in PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsIndocyanine GreenNanoparticlesPhotochemotherapyPhotosensitizing AgentsFemaleHumansAntigens, CDApoferritinsCell Line, TumorCell SurvivalDrug CarriersFerritinsMCF-7 CellsReceptors, Transferrin

Stichwörter der Autor:innen

breast cancerheavy-ferritin nanocagesindocyanine greenphotodynamic therapytumor-targeted nanoparticles

Substanzen

Antigens, CDApoferritinsCD71 antigenDrug CarriersFerritinsIndocyanine GreenPhotosensitizing AgentsReceptors, Transferrin

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences, Università degli studi di Milano, Milan, Italy.
  • Department of Mechanical Engineering, Politecnico di Milano, Milan, Italy.
  • Environmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
  • Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

ORCID-Profile: Leopoldo Sitia, Paola Saccomandi, Leonardo Bianchi, Marta Sevieri, Cristina Sottani, Raffaele Allevi, Elena Grignani, Serena Mazzucchelli, Fabio Corsi

Zitieren

APA

Sitia, L., Saccomandi, P., Bianchi, L., Sevieri, M., Sottani, C., Allevi, R., Grignani, E., Mazzucchelli, S., & Corsi, F. (2024). Combined Ferritin Nanocarriers with ICG for Effective Phototherapy Against Breast Cancer. International Journal of Nanomedicine, Volume 19, 4263-4278. https://doi.org/10.2147/ijn.s445334

Vancouver

Sitia L, Saccomandi P, Bianchi L, Sevieri M, Sottani C, Allevi R, et al. Combined Ferritin Nanocarriers with ICG for Effective Phototherapy Against Breast Cancer. International Journal of Nanomedicine. 2024;Volume 19:4263-4278. doi:10.2147/ijn.s445334

BibTeX
@article{Sitia2024,
  author = {Sitia, Leopoldo and Saccomandi, Paola and Bianchi, Leonardo and Sevieri, Marta and Sottani, Cristina and Allevi, Raffaele and Grignani, Elena and Mazzucchelli, Serena and Corsi, Fabio},
  title = {Combined Ferritin Nanocarriers with ICG for Effective Phototherapy Against Breast Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  volume = {Volume 19},
  pages = {4263--4278},
  doi = {10.2147/ijn.s445334}
}
Kostenlos starten →